Clinical Updates in Acute Kidney Injury: Improving Outcomes for Patients Treated with High-Dose Methotrexate (HD MTX)

To participate in this activity, please:

Certified for CE by:

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive, Dinah Shore Bldg.
Rancho Mirage, CA 92270
Voice: 760-773-4500
Fax: 760-773-4513
E-mail: contactce@annenberg.net
© 2020, Annenberg Center for Health Sciences at Eisenhower. All rights reserved.

Harborside Medical Education
3131 Princeton Pike, Bldg 1
Lawrenceville, NJ 08648
Voice: 631-629-0602
E-mail: contactCE@hbside.com

Journal of the Advanced Practitioner in Oncology
94 North Woodhull Road
Huntington, NY 11743
Voice: 631-692-0800
Fax: 631-692-0805
E-mail: editor@advancedpractitioner.com

Statement of Credit—Participants who successfully complete this activity (including scoring a minimum of 70% on the learning assessment) and complete and submit the evaluation form will receive a statement of credit.

Disclaimer

This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities, clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Annenberg Center for Health Sciences at Eisenhower educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population. The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by Annenberg Center for Health Sciences at Eisenhower of any specific therapeutics or approaches to diagnosis or patient management.

Product Disclosure

This educational activity may contain discussion of published as well as investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.

 

Course Credit:

0.5 ACPE Contact Hours
0.5 AMA PRA Category 1 CreditsTM
0.5 ANCC Contact Hours
0.5 CA-BRN Contact Hours

Dates:

Opens: 2020-12-09
Closes: 2022-12-08

Target Audience:

The target audience for the case-based activity is APs (including physician assistants [PAs], nurse practitioners [NPs], clinical nurse specialists [CNSs], clinical oncology pharmacists [COPs]) who provide care for patients treated with HD MTX.

This activity is supported by an unrestricted educational grant from BTG International, Inc.

    Presenting Faculty

  • Abby Miske, PharmD, BCOP

    Seattle Cancer Care Alliance

Downloads

This course has no downloads at this time.